Bolt Biotherapeutics, Inc. Annual Operating Lease, Payments in USD from 2020 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Bolt Biotherapeutics, Inc. annual/quarterly Operating Lease, Payments history and growth rate from 2020 to 2024.
  • Bolt Biotherapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $1.2M, a 3.36% increase year-over-year.
  • Bolt Biotherapeutics, Inc. annual Operating Lease, Payments for 2024 was $4.89M, a 3.39% increase from 2023.
  • Bolt Biotherapeutics, Inc. annual Operating Lease, Payments for 2023 was $4.73M, a 1.42% increase from 2022.
  • Bolt Biotherapeutics, Inc. annual Operating Lease, Payments for 2022 was $4.66M, a 49.7% increase from 2021.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $4.89M +$160K +3.39% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-24
2023 $4.73M +$66K +1.42% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-24
2022 $4.66M +$1.55M +49.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $3.11M -$1.03M -24.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-29
2020 $4.14M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.